Musculoskeletal and autoimmune manifestations of HIV, syphilis and tuberculosis

Purpose of reviewThe HIV pandemic continues to increase at an alarming rate, and is the leading cause of death worldwide from a single pathogen. The number of HIV-1-infected individuals currently exceeds 40 million, the majority of whom live in the developing countries of Asia, sub-Saharan Africa and south America. In the past 5 years, there has concurrently been an increase in the reported cases of tuberculosis and primary and secondary syphilis. This review addresses the musculoskeletal and autoimmune manifestations associated with HIV, syphilis and tuberculosis infections or their treatments. Recent findingsDuring HIV infection the immune system becomes dysfunctional because of the coexistence of immunodeficiency and immune hyperactivity, and a disregulated production or activity of cytokines. Some of these mechanisms explain the development of rheumatic manifestations associated with HIV infection. Highly active antiretroviral therapy changes the course of HIV infection and the spectrum of the HIV-associated rheumatic manifestations. New syndromes such as the immune reconstitution inflammatory syndrome have emerged. HIV, tuberculosis and syphilis infections offer special epidemiological, clinical, and therapeutic challenges. SummaryThese observations highlight the complexity and multiplicity of the interactions between the pathogen and host that could result in the development of rheumatic manifestations.

[1]  Patrick Chariot,et al.  Skeletal muscle involvement in human immunodeficiency virus (HIV)–infected patients in the era of highly active antiretroviral therapy (HAART) , 2005, Muscle & nerve.

[2]  P. Njobvu,et al.  Human immunodeficiency virus related reactive arthritis in Zambia. , 2005, The Journal of rheumatology.

[3]  A. Davidson,et al.  Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infection. , 2005, The Journal of rheumatology.

[4]  L. Jacobsson,et al.  Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. , 2005, Arthritis and rheumatism.

[5]  M. Adhikari,et al.  Arthritis in association with human immunodeficiency virus infection in Black African children: causal or coincidental? , 2005, Rheumatology.

[6]  J. Gómez-Reino,et al.  Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. , 2005, Arthritis and rheumatism.

[7]  Geoffrey H. Holm,et al.  Distinct Mechanisms of CD4+ and CD8+ T-Cell Activation and Bystander Apoptosis Induced by Human Immunodeficiency Virus Type 1 Virions , 2005, Journal of Virology.

[8]  M. Shaffer,et al.  Knee and hip arthroplasty infection rates in persons with haemophilia: a 27 year single center experience during the HIV epidemic , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  N. Jones,et al.  Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation1 , 2005, The Journal of Immunology.

[10]  M. Weinstein,et al.  Infections of the spine in patients with human immunodeficiency virus. , 2005, The Journal of bone and joint surgery. American volume.

[11]  C. Lacey,et al.  Characteristics of Autoimmune Thyroid Disease Occurring as a Late Complication of Immune Reconstitution in Patients With Advanced Human Immunodeficiency Virus (HIV) Disease , 2005, Medicine.

[12]  M. Salmon,et al.  A Chemokine-Dependent Stromal Induction Mechanism for Aberrant Lymphocyte Accumulation and Compromised Lymphatic Return in Rheumatoid Arthritis , 2005, The Journal of Immunology.

[13]  C. López-Larrea,et al.  The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome. , 2005, Arthritis and rheumatism.

[14]  C. Strady,et al.  Osteonecrosis in Six HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy , 2004, The Annals of pharmacotherapy.

[15]  I. Byren,et al.  Tumid lupus erythematosus occurring following highly active antiretroviral therapy for HIV infection: a manifestation of immune restoration. , 2004, Journal of the American Academy of Dermatology.

[16]  Z. Bentwich,et al.  Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy , 2004, Clinical Microbiology Reviews.

[17]  M. Färkkilä,et al.  Immune activation in the small intestine in patients with rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[18]  M. García-Carrasco,et al.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients , 2004, Annals of the rheumatic diseases.

[19]  S. Resino,et al.  HIV‐infected children with moderate/severe immune‐suppression: changes in the immune system after highly active antiretroviral therapy , 2004, Clinical and experimental immunology.

[20]  P. Price,et al.  Immune restoration disease after antiretroviral therapy , 2004, AIDS.

[21]  Clare Baecher-Allan,et al.  Suppressor T Cells in Human Diseases , 2004, The Journal of experimental medicine.

[22]  J. V. van Horn,et al.  Increase of bone and joint tuberculosis in The Netherlands. , 2004, The Journal of bone and joint surgery. British volume.

[23]  J. Doweiko,et al.  Syphilis in the HIV Era , 2004, Emerging infectious diseases.

[24]  D. Clifford,et al.  HIV-associated neuromuscular weakness syndrome , 2004, AIDS.

[25]  A. Otaka,et al.  Identification of a CXCR4 antagonist, a T140 analog, as an anti‐rheumatoid arthritis agent , 2004, FEBS letters.

[26]  H. Ntsiba,et al.  Is inflammatory joint disease in HIV-infected patients a form of spondyloarthropathy? , 2004, Joint, bone, spine : revue du rhumatisme.

[27]  A. Mastroianni.  Emergence of Sjögren's syndrome in AIDS patients during highly active antiretroviral therapy. , 2004, AIDS.

[28]  Z. Al-Kadhimi,et al.  HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. , 2004, AIDS patient care and STDs.

[29]  D. Denuyl,et al.  Progression of HIV to AIDS: a protective role for HLA-B27? , 2004 .

[30]  A. Berman,et al.  Human immunodeficiency virus-associated rheumatic disorders in the HAART era. , 2004, The Journal of rheumatology.

[31]  J. Tehranzadeh,et al.  Musculoskeletal disorders associated with HIV infection and AIDS. Part I: Infectious musculoskeletal conditions , 2004, Skeletal Radiology.

[32]  Jeannie S. Huang,et al.  Reduced bone density in HIV-infected women , 2004, AIDS.

[33]  S. Lawn,et al.  Therapy for Severe Histoplasmosis: What’s Best? , 2010 .

[34]  R. Schmidt,et al.  Adverse events of desirable gain in immunocompetence: the Immune Restoration Inflammatory Syndromes. , 2003, Autoimmunity reviews.

[35]  S. Lawn.  AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. , 2004, The Journal of infection.

[36]  R. Bianchi,et al.  Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children. , 2004, The Journal of clinical endocrinology and metabolism.

[37]  Congenital syphilis--United States, 2002. , 2004, MMWR. Morbidity and mortality weekly report.

[38]  K. Stanecki,et al.  AIDS epidemic update December 2004. , 2004 .

[39]  S. Rantapää-Dahlqvist,et al.  Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus , 2003, Lupus.

[40]  D. Kyriaki,et al.  Paucity of Sjogren-like syndrome in a cohort of HIV-1-positive patients in the HAART era. Part II. , 2003, Rheumatology.

[41]  J. Gómez-Reino,et al.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. , 2003, Arthritis and rheumatism.

[42]  M. Rafii,et al.  Advanced imaging of tuberculosis arthritis. , 2003, Seminars in musculoskeletal radiology.

[43]  J. Reveille,et al.  Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. , 2003, Arthritis and rheumatism.

[44]  J. Reveille,et al.  Articular manifestations of human immunodeficiency virus infection. , 2003, Best practice & research. Clinical rheumatology.

[45]  A. Malaviya,et al.  Arthritis associated with tuberculosis. , 2003, Best practice & research. Clinical rheumatology.

[46]  E. Breen.  Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. , 2002, Pharmacology & therapeutics.

[47]  C. Dreezen,et al.  Rheumatological complications associated with the use of indinavir and other protease inhibitors , 2002, Annals of the rheumatic diseases.

[48]  S. Lawn,et al.  Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection , 2001, Clinical Microbiology Reviews.

[49]  H. Brühl,et al.  Depletion of CCR5-Expressing Cells with Bispecific Antibodies and Chemokine Toxins: A New Strategy in the Treatment of Chronic Inflammatory Diseases and HIV , 2001, The Journal of Immunology.

[50]  M. B. Moore,et al.  Congenital Syphilis in the United States , 1963, Clinical pediatrics.

[51]  W. J. Brown,et al.  Primary and secondary syphilis in the United States. , 1961, Public health reports.